ns T to.M:Okada,H:Yashiki.T:Shir (41)gom son 92 Transdermal Dr 198536 (42)80 06) M.Exte Control of Drug 3795-799 (44) 19 ans ck H:L 长.om porous polymer matrice。b彩_scillatin3 magnetic dy 84 70 en8 e5Mg9o19a7,2”.1367-1372 (20)sele m】 (1)micro W. Dou eMed.In press (49 1996,193-3 absorption by the ,213 51) Res.997.74.361 he AERx aerosol d drug delivery. M L:M (26F 9269 54)L ger.R.:Vacanti.J.Artificial Organs.Sci Am.1995.273.100- 281 P.:Mar ta.M r.R.B SUp0L1987,8.32-343 (30)Laurenci tayde. 23-9 ices.Ped.Surg.1988 (31)Brer A 15.7010 101 60 5.M:Lance .N:Jor Mater.Res.1994.2 62 189 35 R.Eac e6a % 64 amic 98.7419 (65)Va -12 38) tewpgicl5i3gremdeaiforsmockingcesation (66)Lar Aa5eac8-%A2 (39)Kost,Leon Lang Effects o acLanger,R.Tissue Engineering Lance199,354.32- (67) 10 ACOOUNTS OF CHEMICAL RESEARCH/VOL33,NO.2,2000 (14) Rhine, W.; Hsieh, D. S. T.; Langer, R. Polymers for sustained macromolecules release: procedures to fabricate reproducible delivery systems and control release kinetics. J. Pharm. Sci. 1980, 69, 265-270. (15) Ogawa, Y.; Yamamoto, M.; Okada, H.; Yashiki, T.; Shimamoto, T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid and copoly(lactic/glycolic) acid. Bull. Chem. Pharm. 1985, 36, 1095-1103. (16) Johnson, O. L.; Cleland, J. L.; Lee, H. J.; Charmis, M.; Duenas, E.; Jaworowicz, W.; Shepard, D.; Shahzamani, A.; Jones A. J. S.; Putney, S. D. A month-long effect from a single injection of microencapsulated human growth hormone. Nature Med. 1996, 3, 795-799. (17) Edelman, E.; Brown, L.; Langer, R. In-vitro and in vivo kinetics of regulated drug release from polymer matrices by oscillating magnetic fields. J. Biomed. Mater. Sci. 1978, 21, 339-353. (18) Edelman, E.; Kost, J.; Bobeck, H.; Langer, R. Regulation of drug release from porous polymer matrices by oscillating magnetic fields. J. Biomed. Mater. Res. 1985, 19, 67-83. (19) Kost, J.; Wolfrum, J.; Langer, R. Magnetically controlled insulin release in diabetic rats. J. Biomed. Res. 1987, 21, 1367-1373. (20) Santini, J. T., Jr.; Cima, M. J.; Langer, R. A controlled release microchip. Nature 1999, 397, 335-338. (21) Kwon, I. C.; Bae, Y. H.; Kim, S. W. Electrically erodible polymer gel for controlled release of drugs. Nature 1991, 354, 291-293. (22) Siegel, R. A.; Falamarzian, M.; Firestone, B. A.; Moxley, B. C. pH￾controlled release from hydrophobic/polyelectrolyte copolymer hydrogels. J. Controlled Release 1988, 8, 179-182. (23) Hoffman, A. S.; Afrassiabi, A.; Doug, L. C. Thermally reversible hydrogels: II. delivery and selective removal of substances from aqueous solutions. J. Controlled Release 1986, 4, 213-222. (24) Heller, J. Feedback-controlled drug delivery. In Controlled drug delivery: challenges and strategies; Park, K., Ed.; American Chemical Society: Washington, DC, 1997; pp 127-146. (25) Peppas, N. A. Hydrogels and drug delivery. Curr. Opin. Colloid Interface Sci. 1997, 2, 531-537. (26) Peppas, N. A.; Langer, R. New challenges in biomaterials. Science 1994, 263, 1715-1720. (27) Domb, A.; Langer, R. Polyanhydrides: I. preparation of high molecular weight polyanhydrides. J. Polym. Sci. 1987, 25, 3373- 3386. (28) Leong, K. W.; Brott, B. C.; Langer, R. Bioerodible polyanhydrides as drug-carrier matrices: I. characterization, degradation and release characteristics. J. Biomed. Mater. Res. 1985, 19, 941-955. (29) Leong, K. W.; D’Amore, P.; Marletta, M.; Langer, R. Bioerodible polyanhydrides as drug-carrier matrices: II: biocompatibility and chemical reactivity. J. Biomed. Mater. Res. 1986, 20, 51-64. (30) Laurencin, C.; Domb, A.; Morris, C.; Brown, V.; Chasin, M.; McConnell, R.; Lange, N.; Langer, R. Poly(anhydride) administra￾tion in high doses in vivo: studies of biocompatibility and toxicology. J. Biomed. Mater. Res. 1990, 24 (11), 1463-1481. (31) Brem, H.; Kader, A.; Epstein, J. I.; Tamargo, R. J.; Domb, A.; Langer, R., Leong, K. W. Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain. Sel. Cancer Ther. 1989, 5, 55-65. (32) Brem, H.; Ahn, H.; Tamargo, R. J.; Domb, A.; Langer, R.; Leong, K. W. A biodegradable polymer for intracranial drug delivery: A radiological study in primates. Am. Assoc. Neurol. Surg. 1993, 39 (1), 2-7. (33) Brem, H.; Mahaley, S.; Vick, N. A.; Black, K. L.; Schold, C.; Burger, P. C., Friedman A. H.; Ciric I. S.; Eller T. W.; Cozzens J. W.; Kenealy J. N. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg. 1991, 74, 441- 446. (34) Brem, H.; Piantidosi, S.; Burger, P. C.; Walker, M.; Mohr, G.; Muller, P.; Morawetz, R.; Schold, S. C. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery of biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995, 345, 1008-1012. (35) Valtonen, S.; Timonen, U.; Toivanen, P.; Kalimo, H.; Kivipelto, L.; Heiskanen, O.; Unsgaard, G.; Kuurne, T. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 1997, 41, 44-49. (36) Jacobs, M. Conventional Wisdom. Chem. Eng. News 1996, 74 (42), 5. (37) Delgado-Charro, M. B.; Guy, R. Percutaneous penetration and transdermal drug delivery. Dermatology Foundation 1998, 32 (4), 1-12. (38) Henningfield, J. E. Nicotine medications for smoking cessation. New Engl. J. Med. 1995, 333, 1196-1203. (39) Kost, J.; Leong, K.; Langer, R. Effects of Ultrasound on Polymer Degradation and Release of Incorporated Substances. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 7663-7666. (40) Levy, D.; Kost, J.; Meshulam, Y.; Langer, R., Effect of Ultrasound on Transdermal Drug Delivery to Rats and Guinea Pigs. J. Clin. Invest. 1989, 83, 2074-2078. (41) Bommannan, D.; Menon, G. K.; Okuyama, H.; Elias, P. M.; Guy, R. H. Sonophoresis. II. Examination of the Mechanism(s) of Ultrasound-Enhanced Transdermal Drug Delivery. Pharm. Res. 1992, 9, 1043-1047. (42) Bommannan, D.; Okuyama, H.; Stauffer, P.; Guy, R. H. Sono￾phoresis. I. The Use of Hugh-Frequency Ultrasound to Enhance Transdermal Drug Delivery. Pharm. Res. 1992, 9, 559-564. (43) Mitzaki, S.; Mizuoka, O.; Takada, M. External Control of Drug Release and Penetration: Enhancement of the Transdermal Absorption of Indomethacin by Ultrasound Irradiation. J. Pharm. Pharmacol. 1990, 43, 115-116. (44) Tachibana, K. Transdermal Delivery of Insulin to Alloxan-Diabetic Rabbits by Ultrasound Exposure. Pharm. Res. 1992, 9, 952-954. (45) Mitragotri, S.; Edwards, D.; Blankschtein, D.; Langer, R. A Mecha￾nistic Study of Ultrasonically Enhanced Transdermal Drug Deliv￾ery, J. Pharm. Sci. 1995, 84, 697-706. (46) Mitragotri, S.; Blankschtein, D.; Langer, R. Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res. 1996, 13, 411-420. (47) Mitragotri, S.; Blankschtein, D.; Langer, R. Ultrasound-mediated transdermal protein delivery. Science 1995, 269, 850-853. (48) Kost, J.; Mitragotri, S.; Gabbay, R. A.; Pishko, M.; Langer, R. Ultrasound for non-invasive monitoring of glucose and other analytes. Nature Med. In press. (49) Niven, R. W. Delivery of biotherapeutics by inhalation aerosol. Crit. Rev. Therap. Drug Carrier Syst. 1995, 12, 151-231. (50) Patton, J. S. Mechanisms of macromolecule absorption by the lungs. Adv. Drug Deliv. Rev. 1996, 19, 3-36. (51) Schuster, J.; Rubsamen, R.; Lloyd, P.; Lloyd, J. The AERx aerosol delivery system. Pharm. Res. 1997, 14, 354-357. (52) Edwards, D. A.; Hanes, J.; Caponetti, G.; Hrkach, J.; Ben-Jebria, A.; Eskew, M. L.; Mintzes, J.; Deaver, D.; Lotan, N.; Langer, R. Large porous aerosols for pulmonary drug delivery. Science 1997, 276, 1868-1871. (53) Langer, R.; Vacanti, J. Tissue Engineering. Science 1993, 260, 920- 926. (54) Langer, R.; Vacanti, J. Artificial Organs. Sci. Am. 1995, 273, 100- 103. (55) Folkman, J.; Haudenschild, C. Angiogenesis in vitro. Nature 1980, 288, 855-860. (56) Bissell, M. J.; Barcellos-Hoff, M. H. The Influence of Extracellular Matrix on Gene Expression: Is Structure the Message? J. Cell. Sci., Suppl. 1987, 8, 327-343. (57) Vacanti, J.; Morse, M. A.; Saltzman, W. M.; Domb, A. J.; Perez￾Atayde, A.; Langer, R. Selective Cell Transplantation Using Bioabsorbale Artificial Polymers as matrices. J. Ped. Surg. 1988, 23, 3-9. (58) Cima, L. G.; Vacanti, J. P.; Vacanti, C.; Ingber, D.; Mooney, D.; Langer, R. Tissue Engineering by Cell Transplanation Using Degradable Polymer Substrates. J. Biomed. Eng. 1991, 113, 143- 151. (59) Barrera, D. A.; Zylstra, E.; Lansbury, P. T.; Langer, R. Synthesis and RGD Peptide Modification of a New Biodegradable Copoly￾mer System: Poly(Lactic Acid-co-Lysine). J. Am. Chem. Soc. 1993, 115, 11010-11011. (60) Cook, A. D.; Hrkach, J. S.; Gao, N. N.; Johnson, I. M.; Pajvani, U. B.; Cannizzaro, S. M.; Langer, R. Characterization and develop￾ment of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J. Biomed. Mater. Res. 1997, 35, 513-523. (61) Mooney, D. J.; Park, S.; Kaumann, P. M.; Sano, K.; McNamara, K.; Vacanti, J. P.; Langer, R. Biodegradable sponges for hepato￾cyte transplantation. J. Biomed. Mater. Res. 1994, 29, 959-966. (62) Mikos, A.; Bao, Y.; Ingber, D. E.; Vacanti, J. P.; Langer, R. Preparation of poly(glycolic acid) bonded fiber structures for cell transplantation. J. Biomed. Med. Res. 1993, 27, 183-189. (63) Freed, L.; Vunjak-Novakovic, G.; Biron, R.; Eagles, D.; Lesnoy, D.; Barlow, S.; Langer, R. Biodegradable Polymer Scaffolds for Tissue Engineering. Bio/Technology 1994, 12, 689-693. (64) Vunjak-Novakovic, G.; Obradovic, B.; Martin, I.; Bursac, P.; Langer, R. Dynamic Cell Seeding of Polymer Scaffolds for Cartilage Tissue Engineering. Biotechnol. Progress 1998, 14, 193-202. (65) Vacanti, C.; Langer, R.; Schloo, B.; Vacanti, J. P. Synthetic Polymers Seeded with Chondrocytes Provide a Template for New Cartilage Formation. J. Plastic Surg. 1991, 88, 753-759. (66) Langer, R.; Vunjak, G.; Freed, L.; Atala, A.; Vacanti, C.; Vacanti, J. Tissue Engineering: Biomedical Applications. Tissue Eng. 1995, 1, 151-162. (67) Vacanti, J.; Langer, R. Tissue Engineering. Lancet 1999, 354, 32- 34. Biomaterials in Drug Delivery and Tissue Engineering Langer 100 ACCOUNTS OF CHEMICAL RESEARCH / VOL. 33, NO. 2, 2000